Form 4: Nephros Inc. Director Arthur Amron Reports Stock Transactions

Director Arthur Amron reports purchasing 7,000 shares of Nephros Inc. and receiving an in-kind distribution of 91,463 shares following separation from Wexford Capital.

Summary

• Arthur Amron, a director of Nephros Inc., filed a Form 4 detailing changes in beneficial ownership.
• On March 12, 2024, Amron purchased 7,000 shares of common stock at a weighted average price of $2.4471 per share.
• On March 13, 2024, Amron received an in-kind distribution of 91,463 shares from Wexford Capital LP in connection with his separation from service as an employee.
• Following these transactions, Amron directly owns 98,463 shares of Nephros Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Industry Context

This filing reflects insider activity, which is closely monitored by investors for insights into management's perspective on the company's prospects. The in-kind distribution is related to the director's separation from Wexford Capital.

Stakeholder Impact

• Shareholders may be interested in the insider's transactions as an indicator of confidence in the company.
• The in-kind distribution from Wexford Capital LP may be of interest to stakeholders monitoring the relationship between Nephros Inc. and Wexford Capital.

Key Dates